Summary
- Current Price
- As of today, HRTX price is $0.97, down -5.25% in the most recent trading session on
- Current Price All-Time High
- HRTX price is currently -99.93% below its historical high of $1,290.00 set on
- Market Cap
- HRTX current market cap is $177M, down -50.71% year-over-year
- PE Ratio
- HRTX PE ratio is unknown
- Revenue
- HRTX current annual revenue is $154.90M, up +7.36% year-over-year
- Next Earnings
- The next earnings release for HRTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Heron Therapeutics, Inc. |
| Ticker | NASDAQ: HRTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | herontx.com |
| Employees | 122 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.97 | ||
| Price, 1D Change | -5.25% | |
| $177M | ||
| - | ||
| - | ||
| 0.95 | ||
| $155M | ||
| Revenue, 1Y Change | +7.36% | |
| $0.00 | ||
| EPS, 1Y Change | +100.00% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | APPA | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| EPS Estimate | N/A | -$0.03 |
| EPS Est. Change | N/A | - |
| $154.90M | ||
| Revenue Estimate | N/A | $175.07M |
| Revenue Est. Change | N/A | +13.02% |
| $0.97 | ||
| Price Target | - | $4.00 |
| Price Tgt. Change | - | +313.91% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.12 | -$0.09 | +25.75% | |
| -$0.05 | $0.00 | +100.00% | |
| -$0.03 | N/A | - | |
| $0.51 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $140.87M | $144.29M | +2.43% | |
| $153.87M | $154.90M | +0.67% | |
| $175.07M | N/A | +13.02% | |
| $210.60M | N/A | +35.96% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -59.05% | ||
| -58.16% | ||
| -50.71% | ||
| -35.62% | ||
| +7.36% | ||
| +43.87% | ||
| +100.00% | ||
| +100.00% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.97 | ||
| $1.47 | ||
| SMA 200 vs Price | +51.99% | |
| $1.29 | ||
| SMA 50 vs Price | +33.24% | |
| 0.95 | ||
| $0.09 | ||
| 33.09 | ||
| 90.67% | ||
| 64.34% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $154.90M | ||
| $0.00 | ||
| $0.00 | ||
| 73.31% | ||
| -$2.54M | ||
| -1.64% | ||
| -$20.20M | ||
| -13.04% | ||
| -$224.00K |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 9.81 | ||
| 2.48 | ||
| 1.51 | ||
| - | ||
| 2 | ||
| -3.40 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1.14 | ||
| 13.34 | ||
| 982.64 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $13.28M | ||
| $46.63M | ||
| $670.88M | ||
| $238.07M | ||
| $656.54M | ||
| $96.10M | ||
| $140.64M | ||
| $0.00 | ||
| $8.99M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $175.10M | ||
| $116.10M | ||
| $41.35M | ||
| $103.67M | ||
| $2.31M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$27.59M | ||
| $16.01M | ||
| $14.43M | ||
| $317.00K | ||
| -$27.91M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Needham | → | |
| HC Wainwright & Co. | ||
| Needham | → | |
| Needham | → | |
| Needham | → | |
| Needham | → | |
| Needham | → | |
| Needham | → | |
| Rodman & Renshaw |
Analyst sentiment
Institutional ownership
Screeners with HRTX
FAQ
What is the ticker symbol for Heron Therapeutics, Inc.?
The ticker symbol for Heron Therapeutics, Inc. is NASDAQ:HRTX
Does Heron Therapeutics, Inc. pay dividends?
No, Heron Therapeutics, Inc. does not pay dividends
What sector is Heron Therapeutics, Inc. in?
Heron Therapeutics, Inc. is in the Healthcare sector
What industry is Heron Therapeutics, Inc. in?
Heron Therapeutics, Inc. is in the Biotechnology industry
What country is Heron Therapeutics, Inc. based in?
Heron Therapeutics, Inc. is headquartered in United States
When did Heron Therapeutics, Inc. go public?
Heron Therapeutics, Inc. initial public offering (IPO) was on August 26, 1987
Is Heron Therapeutics, Inc. in the S&P 500?
No, Heron Therapeutics, Inc. is not included in the S&P 500 index
Is Heron Therapeutics, Inc. in the NASDAQ 100?
No, Heron Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Heron Therapeutics, Inc. in the Dow Jones?
No, Heron Therapeutics, Inc. is not included in the Dow Jones index
When was Heron Therapeutics, Inc. last earnings report?
Heron Therapeutics, Inc.'s most recent earnings report was on February 26, 2026
When does Heron Therapeutics, Inc. report earnings?
The next expected earnings date for Heron Therapeutics, Inc. is May 5, 2026
Data Sources & References
- HRTX Official Website www.herontx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/818033/000119312526073515/0001193125-26-073515-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/818033/000119312526073515/0001193125-26-073515-index.htm
- HRTX Profile on Yahoo Finance finance.yahoo.com/quote/HRTX
- HRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hrtx